Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 21 22 23 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Novartis–GSK: ofatumumab, 201508 acquisition of all rights to all indications for Arzerra for up to $1.034b by Novartis 2015-08-21
Nanodigmbio–Genetrix (ES): genomic reagents, 201508– distribution of Sygnis TruePrime + SunScript RT products in China by Nanodigmbio 2015-08-20
EBS Technologies–Earlybird: investment, 201508 financing round totalling €1.1m led by returning investors Earlybird + HTGF 2015-08-19
EBS Technologies–High-Tech Gründerfonds: investment, 201508 financing round totalling €1.1m led by returning investors Earlybird + HTGF 2015-08-19
EBS Technologies–PERSON: investment, 201508 financing round €1.1m led by Earlybird + HTGF plus 3 private investors incl R Christine 2015-08-19
EBS Technologies–SEVERAL: investment, 201508 financing round €1.1m led by Earlybird + HTGF plus 3 private investors incl R Christine 2015-08-19
Kapa Biosystems–Roche: investment, 201508 acquisition €na by Roche 2015-08-19
Celsus Therapeutics–SEVERAL: investment, 201508– private placement $75m net $70m of ADSs led by Deerfield 2015-08-18
Kuros–Huntsworth: public relations, 201508 service existent media relations by Citigate Dewe Rogerson 2015-08-18
Kuros–SEVERAL: investment, 201508 financing round CHF15m led by LifeCare Partners + Life Sciences Partners 2015-08-18
GeneWeave–Roche: investment, 201508– acquisition $190m upfront + $235m product related milestones 2015-08-13
Checkmate–Cytos Biotechnology: cancer immunotherapy, 201508– excl license to CYT003 + VLP technology for cancer $90m milestones + royalties 2015-08-12
Checkmate–SEVERAL: investment, 201508 financing round Series A $20m from Sofinnova Ventures + venBio 2015-08-12
Sanofi–Apeiron: cancer immunotherapy, 201508– collab r+d small-molecules of Evotec + Apeiron + Sanofi 2015-08-10
Sanofi–Evotec: cancer immunotherapy, 201508– collab r+d small-molecules of Evotec + Apeiron + Sanofi 2015-08-10
JenaValve–SEVERAL: investment, 201508 financing round $26.5m including Gimv 2015-08-07
Nomad Bioscience–Denka: investment, 201508–201708 acquisition up to €75m of 51% share in Icon Genetics GmbH + after 2y acquiring rest by Denka 2015-08-07
Sanofi–Evotec: drug discovery, 201508– collab research beta cell replacement therapy for diabetes 2015-08-07
Deutsche Biotech Innovativ–Kirchhoff Consult: public relations, 201508 service existent by Kirchhoff Consult AG 2015-08-06
MorphoSys–G7 Therapeutics: therapeutic antibodies, 201508– collab to develop therap ABs targeting GPCRs 2015-08-04
AdvanceCor–SEVERAL: investment, 201508 2nd financing round €2.2m led by MIG AG inkl Bayern Kapital + Bio-M + HTGF + KfW Bank + founders 2015-08-01
Amgen–Novartis: CNS drugs, 201508– collab ww developm + commercialisation drugs for Alzheimer’s + migraine 2015-08-01
Deutsche Biotech Innovativ–SEVERAL: investment, 201508–201511 capital increase €1.6m 49k new shares €33.5/share out of 596.4k shares on public offer 2015-08-01
Novartis–CSL: investment, 201507 acquisition $275m of Novartis influenza vaccine business by CSL Ltd 2015-07-31
Santhera–SEVERAL: investment, 201507–201508 capital increase $28.6m 2015-07-31
DSM–Evonik: animal feed, 201507– collab developm algae-based production of omega-3 fatty acids for animal nutrition 2015-07-29
Mereo BioPharma–Novartis: investment, 201507 Novartis receives equity stake in consideration for acquisition of 3 programmes from Novartis by Mereo 2015-07-29
Mereo BioPharma–SEVERAL: investment, 201507 financing round $118m from Woodford + Invesco Perpetual at launch of company 2015-07-29
Apogenix–R-Biopharm: cancer companion diagnostics, 201507– collab developm CDx for Apogenix’ CD95 ligand inhibitor APG101 2015-07-28
Boehringer–Hanmi: kinase inhibitor, 201507–201609 TERMINATED license to HM61713 ww excl KR + CN + HK with $50m upfront + $680m milestones + royalties 2015-07-28
Boehringer–Hikma: investment, 201507– acquisition of Roxane Labs $2.65b w $1.18m in cash + 40m new Hikma shares + addit $125m milestones 2015-07-28
Hikma–Boehringer: investment, 201507– acquisition 40m new shares £940m representing 16.71% as part of sale of Roxane by BI to Hikma 2015-07-28
MRC Technology–Univ Göttingen: therapeutic antibodies, 201507– collab developm ABs targeting amyloid beta 4-x for Alzheimer’s Disease 2015-07-28
Pieris–SEVERAL: investment, 201507 public offering $25m+$3.3m with 9.1m+1.2m new shares common stock $2.75/share 2015-07-28
Protembis–SEVERAL: investment, 201507 seed financing round 7-digit € incl Innovationsstarter Fonds + Geratherm + angel investors 2015-07-28
Leon-Nanodrugs–Albany Private Equity: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Albany Private Equity Holding 2015-07-27
Leon-Nanodrugs–CD-Venture: investment, 201507 financing round Series A 1st closing totalling €18.5m incl CD-Venture 2015-07-27
Leon-Nanodrugs–LifeCare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl LifeCare Partners 2015-07-27
Leon-Nanodrugs–MJR PharmJet: nanoparticle drug delivery technology, 201507 collab existent 2015-07-27
Leon-Nanodrugs–OTHER: investment, 201507 financing round Series A 1st closing totalling €18.5m incl non-disclosed German Family Office 2015-07-27
Leon-Nanodrugs–SEVERAL: investment, 201507 financing round Series A 1st closing €18.5m led by TVM Capital Life Science 2015-07-27
Leon-Nanodrugs–Signet Healthcare Partners: investment, 201507 financing round Series A 1st closing totalling €18.5m incl Signet 2015-07-27
Leon-Nanodrugs–TVM: investment, 201507 financing round Series A 1st closing totalling €18.5m led by TVM Capital Life Science 2015-07-27
Merck (DE)–Celares: protein pegylation services, 201507– collab Merck Millipore offering PEG services tog with Celares GmbH 2015-07-27
Medigene–QVT: investment, 201507 QVT owns 15.6% of Medigene shares after capital increase 2015-07-25
Poxel–MacDougall Biomedical Communications: public relations, 201507 service existent IR + PR in EU + US 2015-07-24
Scienion–Anteo Technologies: protein microarray technology, 201507– collab developm protein microarray consumables using Mix&Go technology 2015-07-24
BeneChill–Odlander Fredrikson: investment, 201507 existent investment listed on HealthCap web site 2015-07-23
Merck (DE)–BioMed X: pharma research, 201507– collab Merck Serono extension funding two cancer research groups at BioMed X 2015-07-23
Cevec–SEVERAL: investment, 201507 financing round €4.5m from Peppermint + Creathor Venture + NRW.Bank + Investtodate et al 2015-07-22
Leukocare–LifeCare Partners: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors 2015-07-22
Leukocare–SEVERAL: investment, 201507 financing round led by LifeCare Partners + incl new + existing investors 2015-07-22
Memo Therapeutics–SEVERAL: investment, 201507 financing round Series A CHF2.3m from Swiss investors incl EVA Basel + Redalpine + Zürcher Kantonalbank 2015-07-22
Merck (DE)–Genedata: bioinformatics, 201507– supply Merck Serono implements Genedata Biologics as workflow platform for biopharma RnD 2015-07-22
Allergan–Molecular Partners: ophthalmics, 201507– collab expansion of DARPin alliance in ophthalmology 2015-07-21
Anagnostics–Cube Dx: investment, 201507 acquisition of all assets of Anagnostics Bioanalysis GmbH by Cube Dx GmbH 2015-07-21
Medigene–Aviva: investment, 201507 acquisition 1.97m shares by Aviva plc representing 10.01% of Medigene shares after capital increase 2015-07-20
BioAnalytica GenoType–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Bioarray (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Cialab (ES)–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Genetadi Biotech–Sophia Genetics: bioinformatics, 201507– supply use of Sophia DDM platform for provision of NGS-based services 2015-07-16
Genycell–Sophia Genetics: bioinformatics, 201507– distribution of Sophia DDM platform for clinical NGS data analysis in Iberia by Genycell 2015-07-16
Immunocore–Credit Suisse: investment banking, 201507 supply service Credit Suisse is advisor on $320m Series A round 2015-07-16
Immunocore–Malin Corp: investment, 201507 financing round Series A totalling $320m (£205m) incl new investor Malin Corp plc 2015-07-16
Immunocore–SEVERAL: investment, 201507 financing round Series A $320m (£205m) private from new + existing investors 2015-07-16
Piqur Therapeutics–SEVERAL: investment, 201507 financing round Series A2 CHF18m incl returning investor Versant Ventures 2015-07-16
Piqur Therapeutics–Versant Ventures: investment, 201507 financing round Series A2 totalling CHF18m incl returning investor Versant Ventures 2015-07-16
Accurate Mass Scientific–CovalX: mass spectrometry, 201507– collab AMS new Australian distributor of CovalX High-Mass systems + CRO analytics services 2015-07-15
Canbridge Life Sciences–Apogenix: cancer drug, 201507– license developm + commercialisation of APG101 in Greater China 2015-07-15
Volution Immuno Pharmaceuticals–Celsus Therapeutics: investment, 201508– reverse merger acqu of VIP by Celsus to be renamed Akari Therapeutics 2015-07-13
Apceth–Univ Cologne: T-cell immunotherapy, 201507– collab with CMMC use of MSCs for local activation of CAR T-cells within tumours 2015-07-10
Insilico Biotechnology–SEVERAL: investment, 201507 capital increase 2015-07-10
SGS–Northern Exposure PR: public relations, 201507 service existent for SGS Life Sciences by NEPR 2015-07-10
JeNaCell–Evonik: investment, 201507 financing round Series A incl new investor Evonik Industries 2015-07-09
JeNaCell–High-Tech Gründerfonds: investment, 201507 financing round Series A incl existing investor HTGF 2015-07-09
JeNaCell–SEVERAL: investment, 201507 financing round Series A from Evonik + bm-t + Sparkasse Jena + HTGF + STIFT 2015-07-09
InSphero–HP Wild Holding: investment, 201507 Series C financing CHF20m from HP Wild Holding AG 2015-07-08
Qiagen–Seegene: molecular diagnostics, 201507– collab ww marketing validated multi-plexed Seegene PCR tests for QIAsymphony RGQ MDx system 2015-07-08
Cassiopea–Cosmo Pharmaceuticals: investment, 201507 existent 45.4% shareholder after spin-off of Cassiopea from Cosmo via IPO at SIX 2015-07-06
Cellca–Sartorius: investment, 201507 acquisition of Cellca GmbH by Sartorius Stedim Biotech 2015-07-02
Neovacs–MC Services: public relations, 201507 service existent by MC Services IR in Germany 2015-07-02
Actelion–Qlucore: bioinformatics, 201507– license 3y to Omics Explorer s/w after using it since 2011 2015-07-01
Biotest–Cevec: rec protein production technology, 201507– license to CAP Go technology to Biotest AG 2015-07-01
GNA Biosolutions–Instinctif Partners: public relations, 201507 service existent by Instinctif Partners 2015-07-01
GNA Biosoutions–SEVERAL: investment, 201507 financing round Series B €6m led by new investor Robert Bosch Venture Capital GmbH 2015-07-01
Seres Therapeutics–Nestlé: investment, 201507 equity investment by Nestlé Health Science 2015-07-01
TAmiRNA–EU (govt): grant, 201507– Horizon 2020 SME Instrument Phase I Funding for collab with IPF Vienna 2015-07-01
Spinifex Pharmaceuticals–Novartis: investment, 201506– acquisition €na ANNOUNCED 2015-06-29
Actelion–Max Planck: vaccine technology, 201506 license excl synthetic carbohydrate vaccines for new Vaxillion joint venture from + with Max Planck 2015-06-26
Qiagen–Zörgiebel Group: molecular diagnostics, 201506– collab founding joint venture Biotye Innovation GmbH to develop MDx companion diagnostics 2015-06-26
Vaxxilon–Actelion: investment, 201506 founding w Max Planck + Actelion as majority owner w committed funding of €30m over 4y in tranches 2015-06-26
BioNTech–Siemens: cancer vaccine, 201506– collab developm + construction automated production facility for IVAC products Siemens Process Automation 2015-06-25
BioNTech–Strüngmann Group: investment, 201506 existent Strüngman family office is majority shareholder of BioNTech AG 2015-06-25
Gladstone Institutes–Thermo Fisher: grant, 201506– sponsoring of new Thermo Fisher Proteomics Facility for Disease Target Discovery at Gladstone 2015-06-24
Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply Orbitrap Fusion Tribrid system to new Proteomics Facility at Gladstone 2015-06-24
Gladstone Institutes–Thermo Fisher: mass spectrometer, 201506 supply TSQ Quantiva Triple Quad LC/MS system to new Proteomics Facility at Gladstone 2015-06-24
Thermo Fisher–Gladstone Institutes: mass spectrometry, 201506– collab establ new Thermo Fisher Proteomics Facility at Gladstone in collab w UCSF + QB3 2015-06-24
Ankasa Regenerative–Avalon Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A led by Avalon Ventures 2015-06-23
Ankasa Regenerative–Correlation Ventures: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Correlation 2015-06-23
Ankasa Regenerative–Heraeus: investment, 201506 financing round Series A 1st tranche totalling $8.5m of $17m Series A incl Heraeus Medical 2015-06-23
next pagenext page 1 2 3 ... 21 22 23 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top